Using Patient-Specific Contrast Enhancement Optimizer Simulation Software During the Transcatheter Aortic Valve Implantation—Computed Tomography Angiography in Patients With Aortic Stenosis

Takanori Masuda,Takeshi Nakaura,Toru Higaki,Yoshinori Funama,Yoriaki Matsumoto,Tomoyasu Sato,Tomokazu Okimoto,Keiko Arao,Hiromasa Imaizumi,Shinichi Arao,Atsushi Ono,Junichi Hiratsuka,Kazuo Awai
DOI: https://doi.org/10.1097/rct.0000000000001603
2024-04-08
Journal of Computer Assisted Tomography
Abstract:Objectives This study assessed whether patient-specific contrast enhancement optimizer simulation software (p-COP) can reduce the contrast material (CM) dose compared with the conventional body weight (BW)-tailored scan protocol during transcatheter aortic valve implantation-computed tomography angiography (TAVI-CTA) in patients with aortic stenosis. Methods We used the CM injection protocol selected by the p-COP in group A (n = 30). p-COP uses an algorithm that concerns data on an individual patient's cardiac output. Group B (n = 30) was assigned to the conventional BW-tailored CM injection protocol group. We compared the CM dose, CM amount, injection rate, and computed tomography (CT) values in the abdominal aorta between the 2 groups and classified them as acceptable (>280 Hounsfield units (HU)) or unacceptable (<279 HU) based on the optimal CT value and visualization scores for TAVI-CTA. We used the Mann–Whitney U test to compare patient characteristics and assess the interpatient variability of subjects in both groups. Results Group A received 56.2 mL CM and 2.6 mL/s of injection, whereas group B received 76.9 mL CM and 3.4 mL/s of injection ( P < 0.01). The CT value for the abdominal aorta at the celiac level was 287.0 HU in group A and 301.7HU in group B ( P = 0.46). The acceptable (>280 HU) and unacceptable (<280 HU) CT value rates were 22 and 8 patients in group A and 24 and 6 patients in group B, respectively ( P = 0.76). We observed no significant differences in the visualization scores between groups A and B (visualization score = 3, P = 0.71). Conclusion The utilization of p-COP may decrease the CM dosage and injection rate by approximately 30% in individuals with aortic stenosis compared with the body-weight-tailored scan protocol during TAVI-CTA.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?